Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Engineering / 工學院
  3. Biomedical Engineering / 醫學工程學系
  4. Cancer Treatment Enhancement by Immunostimulant and NK Cell Transfer for Therapeutic Ultrasound-Induced Antitumor Immune Response
 
  • Details

Cancer Treatment Enhancement by Immunostimulant and NK Cell Transfer for Therapeutic Ultrasound-Induced Antitumor Immune Response

Date Issued
2016
Date
2016
Author(s)
Li, Ting-Chuan
DOI
10.6342/NTU201601147
URI
http://ntur.lib.ntu.edu.tw//handle/246246/277673
Abstract
Background: The capability of tumors for modulating anti-tumor immune response and orchestrating an immune permissive microenvironment was reported as one of the cancer hallmarks. Therefore, unlike the past concept of cancer therapy which simply aims at killing tumor cells and ignores the tolerance of the host itself to the immune-mediated attack, the emerging strategy for cancer treatment includes not only extirpating all localized tumor cells, but also arousing a systemic, long-lasting, and tumor-specific immune response synchronously, against tumor growth, recurrence and metastasis to achieve the ultimate objective: prolongation of survival times. In addition, ultrasound hyperthermia has been used against various types of cancer and recent studies demonstrated its potential of activating a systemic anti-tumor immune response. Purpose: To evaluate whether an inducible anti-tumor immunity could be enhanced systemically through combining immunotherapies, in this study we exposed immunogenic moieties from tumor cells by sonicating tumors with pulsed ultrasound hyperthermia (pUSHT) and strengthened the anti-cancer immunity in an all-round way by injecting tumors with OK-432 immunostimulant and adoptive natural killer cell transfer therapy (ACT-NK). Methods and Materials: A bilateral distant tumor model and a rechallenging tumor model were applied in the studies. For the bilateral distant tumor model, male BALB/c mice were inoculated CT26-luc-GFP tumors on both flanks. The treated tumor (right side) underwent a 10-day treatment including four times of pUSHT (once per 3 days), four times of subcutaneous OK-432 injection (3 hours before each pUSHT) and two times of local ACT-NK injection. The distant untreated tumor (left side) was regarded as a non-visualized small tumor used to assess the degree of anti-tumor immune response. For the rechallenging tumor model, a rechallenge tumor was implanted contralaterally on day 10 after the right-sided tumor had experienced a 5-day treatment (days 0~4) and then a surgical removal on day 5. This model was designed to evaluate whether or not the establishment of a long-term active tumor-specific immune memory is strong enough to prevent recurrence. All data was analyzed statistically by independent T-test or ANOVA with Fisher''s LSD test as a multiple comparison tool alternatively, and survival time was evaluated by the Kaplan-Meier method. Results: The results of bilateral distant tumor model showed that the tumor growth rate and growth activity of both treated and distant tumors could be significantly inhibited with OK+pUSHT+NK combined therapy (p value<0.05) and the systemic anti-tumor effect seemed to be prolonged as well. H&E staining results implicated that the necrosis area appeared earlier after the combination treatment. IF staining results also showed a remarkable increase of NK cell infiltration in the central zone of tumors due to the OK+pUSHT+NK therapy. Survival rates significantly increased in both OK+pUSHT and OK+pUSHT+NK groups. In the rechallenging test, all the reimplanted tumors failed to form solid tumors as compared with the control group due to an effective long-lasting anti-tumor immune response which was induced by the combinational treatment. Conclusion: Combining ultrasound hyperthermia and multiple immunotherapies could lead immune system toward an anti-tumor regulation to overcome an immunosuppressive milieu of tumors. This combined approach has a potential to play an important role in the future cancer treatment of solid malignancy to improve the overall therapeutic benefit.
Subjects
ultrasound hyperthermia
immunostimulant OK-432
adoptive NK cell transfer therapy
antitumor immune response
SDGs

[SDGs]SDG3

Type
thesis
File(s)
Loading...
Thumbnail Image
Name

ntu-105-R03548008-1.pdf

Size

23.54 KB

Format

Adobe PDF

Checksum

(MD5):6662119dea228bec58f0dbb17dd79ea9

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science